# A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

> **NCT00236067** · PHASE3 · COMPLETED · sponsor: **Cephalon** · enrollment: 440 (—)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Gabitril

## Key facts

- **NCT ID:** NCT00236067
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 440 (—)
- **Last updated:** 2014-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236067, "A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00236067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*